Literature DB >> 10604984

Cutting edge: tyrosine-independent transmission of inhibitory signals by CTLA-4.

T Cinek1, A Sadra, J B Imboden.   

Abstract

CTLA-4 is an important inhibitor of T cell activation. We used Jurkat cells expressing mutants of murine CTLA-4 to study the structural requirements for inhibitory signaling. We find that signals for the inhibition of IL-2 secretion are delivered efficiently by a CTLA-4 mutant in which both cytoplasmic tyrosines have been replaced by phenylalanines. A CTLA-4 mutant that lacks the carboxyl-terminal half of the intracellular domain also retains the ability to inhibit, but deletion of an additional 11 aa completely abrogates that capability. We conclude that delivery of an inhibitory signal requires the membrane-proximal region of the CTLA-4 cytoplasmic domain and does not depend upon the tyrosine phosphorylation of CTLA-4.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10604984     DOI: 10.4049/jimmunol.164.1.5

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  9 in total

Review 1.  Activation and inhibition of lymphocytes by costimulation.

Authors:  Kenneth A Frauwirth; Craig B Thompson
Journal:  J Clin Invest       Date:  2002-02       Impact factor: 14.808

Review 2.  Cytotoxic T-lymphocyte antigen-4 and programmed death-1 function as negative regulators of lymphocyte activation.

Authors:  Laura L Carter; Beatriz M Carreno
Journal:  Immunol Res       Date:  2003       Impact factor: 2.829

Review 3.  Modulation of CTLA-4 and GITR for cancer immunotherapy.

Authors:  Francesca Avogadri; Jianda Yuan; Arvin Yang; David Schaer; Jedd D Wolchok
Journal:  Curr Top Microbiol Immunol       Date:  2011       Impact factor: 4.291

4.  CTLA-4 and PD-1 receptors inhibit T-cell activation by distinct mechanisms.

Authors:  Richard V Parry; Jens M Chemnitz; Kenneth A Frauwirth; Anthony R Lanfranco; Inbal Braunstein; Sumire V Kobayashi; Peter S Linsley; Craig B Thompson; James L Riley
Journal:  Mol Cell Biol       Date:  2005-11       Impact factor: 4.272

Review 5.  Immune regulatory antibodies: are they the next advance?

Authors:  Jedd D Wolchok; Arvin S Yang; Jeffrey S Weber
Journal:  Cancer J       Date:  2010 Jul-Aug       Impact factor: 3.360

6.  Surface cytotoxic T lymphocyte-associated antigen 4 partitions within lipid rafts and relocates to the immunological synapse under conditions of inhibition of T cell activation.

Authors:  Peter J Darlington; Miren L Baroja; Thu A Chau; Eric Siu; Vincent Ling; Beatriz M Carreno; Joaquín Madrenas
Journal:  J Exp Med       Date:  2002-05-20       Impact factor: 14.307

Review 7.  Confusing signals: recent progress in CTLA-4 biology.

Authors:  Lucy S K Walker; David M Sansom
Journal:  Trends Immunol       Date:  2015-01-09       Impact factor: 16.687

Review 8.  The Role of Immunomodulatory Receptors in the Pathogenesis of HIV Infection: A Therapeutic Opportunity for HIV Cure?

Authors:  Hui Chen; Maha Moussa; Marta Catalfamo
Journal:  Front Immunol       Date:  2020-07-02       Impact factor: 7.561

Review 9.  Description of CD8+ Regulatory T Lymphocytes and Their Specific Intervention in Graft-versus-Host and Infectious Diseases, Autoimmunity, and Cancer.

Authors:  Martha R Vieyra-Lobato; Jorge Vela-Ojeda; Laura Montiel-Cervantes; Rubén López-Santiago; Martha C Moreno-Lafont
Journal:  J Immunol Res       Date:  2018-08-05       Impact factor: 4.818

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.